Insulin Pump Therapy and Its Impact on Hospital Readmissions and Mortality in Adults with Type 1 Diabetes: Insights from a 2022 Nationwide Analysis

Highlight

• Insulin pump therapy is independently associated with a 23% reduction in 30-day hospital readmissions among adults with type 1 diabetes compared to injectable insulin alone.
• In-hospital mortality was lower in insulin pump users, with a 22% adjusted reduction in odds of death during index admission.
• The 2022 Nationwide Readmissions Database provides a nationally representative insight into inpatient outcomes linked to insulin delivery modality in type 1 diabetes.

Study Background and Disease Burden